Table 2

EC50 (nM) calculated from 5-day treatments of lymphoma cell lines with 22-20, 20-22, or a combination of v-mab and e-mab

DaudiRajiRamos
22-20 0.32 0.33 0.20 
20-22 0.50 3.55 1.58 
v-mab + e-mab 17.80 35.48 12.6 
DaudiRajiRamos
22-20 0.32 0.33 0.20 
20-22 0.50 3.55 1.58 
v-mab + e-mab 17.80 35.48 12.6 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal